NCT07263438
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07263438
Title Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial (Phenix)
Acronym Phenix
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire Vaudois
Indications
Therapies
Age Groups: adult | senior
Covered Countries CHE

Facility Status City State Zip Country Details
Universitätsspital Basel RECRUITING Basel Basel 4031 Switzerland Details
Kantonsspital Aarau RECRUITING Aarau Canton of Aargau 5001 Switzerland Details
Bern Inselspital RECRUITING Bern Canton of Bern 3010 Switzerland Details
Luzerner Kantonsspital RECRUITING Lucerne Canton of Lucerne 6000 Switzerland Details
Centre Hospitalier Universitaire Vaudois RECRUITING Lausanne Canton of Vaud 1011 Switzerland Details
Universitätsspital Zürich RECRUITING Zurich Canton of Zurich 8091 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field